CINECA IRIS Institutional Research Information System
IRIS è l'Anagrafe della ricerca dell'Università degli Studi di Trento, e ha lo scopo di raccogliere, documentare, conservare e diffondere, anche ad accesso aperto, la produzione scientifica degli autori afferenti all'Università degli Studi di Trento.
EnglishTyrosine kinase inhibitors (TKIs) are now the mainstay of treatment in many types of cancer. However, their benefit is frequently short-lived, mandating the search for safe potentiation strategies. Cycles of fasting enhance the activity of chemo-radiotherapy in preclinical cancer models and dietary approaches based on fasting are currently explored in clinical trials. Whether combining fasting with TKIs is going to be potentially beneficial remains unknown. Here we report that starvation conditions increase the ability of commonly administered TKIs, including erlotinib, gefitinib, lapatinib, crizotinib and regorafenib, to block cancer cell growth, to inhibit the mitogen-activated protein kinase (MAPK) signaling pathway and to strengthen E2F-dependent transcription inhibition. In cancer xenografts models, both TKIs and cycles of fasting slowed tumor growth, but, when combined, these interventions were significantly more effective than either type of treatment alone. In conclusion, cycles of fasting or of specifically designed fasting-mimicking diets should be evaluated in clinical studies as a means to potentiate the activity of TKIs in clinical use.
Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition / Caffa, Irene; D'Agostino, Vito Giuseppe; Damonte, Patrizia; Soncini, Debora; Cea, Michele; Monacelli, Fiammetta; Odetti, Patrizio; Ballestrero, Alberto; Provenzani, Alessandro; Longo, Valter D; Nencioni, Alessio. - In: ONCOTARGET. - ISSN 1949-2553. - STAMPA. - 2015 / 6:14(2015), pp. 11820-11832.
| Titolo: | Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition | |
| Autori: | Caffa, Irene; D'Agostino, Vito Giuseppe; Damonte, Patrizia; Soncini, Debora; Cea, Michele; Monacelli, Fiammetta; Odetti, Patrizio; Ballestrero, Alberto; Provenzani, Alessandro; Longo, Valter D; Nencioni, Alessio | |
| Autori Unitn: | ||
| Titolo del periodico: | ONCOTARGET | |
| Anno di pubblicazione: | 2015 | |
| Numero e parte del fascicolo: | 14 | |
| Codice identificativo Scopus: | 2-s2.0-84931329276 | |
| Codice identificativo Pubmed: | 25909220 | |
| Codice identificativo WOS: | WOS:000359008200009 | |
| Handle: | http://hdl.handle.net/11572/111762 | |
| Citazione: | Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition / Caffa, Irene; D'Agostino, Vito Giuseppe; Damonte, Patrizia; Soncini, Debora; Cea, Michele; Monacelli, Fiammetta; Odetti, Patrizio; Ballestrero, Alberto; Provenzani, Alessandro; Longo, Valter D; Nencioni, Alessio. - In: ONCOTARGET. - ISSN 1949-2553. - STAMPA. - 2015 / 6:14(2015), pp. 11820-11832. | |
| Appare nelle tipologie: | 03.1 Articolo su rivista (Journal article) |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| Oncotarget - 2015.pdf | Articolo | Versione editoriale (Publisher’s layout) |  | Open Access Visualizza/Apri |
Copyright © 2022